Advancing current approaches to disease management evaluation: capitalizing on heterogeneity to understand what works and for whom

Table 2 Characteristics of the research population

Characteristic	Patients for whom characteristic is known (total =105,056)	Estimate
	% (N)	Mean ± SD
Baseline age	99.9 (105,013)	65.7 ± 11.9
Baseline diabetes duration	71.9 (75,498)	4.8 ± 5.6
Baseline health status
HbA1c (mmol/mol) [target < 53]	71.5 (75,127)	50.2 ± 9.8
LDL cholesterol (mmol/l) [target < 2.5]	55.9 (58,697)	2.6 ± 0.9
SBP (mmHg) [target < 140]	69.9 (73,437)	140.4 ± 18.0
BMI (kg/m²) [target < 25]	60.3 (63,341)	29.7 ± 5.2
	% (N)	% (N)
Diabetes complications^†	94.5 (99,278)
None		84.2 (75,357)
One or more		15.8 (14,165)
Smoking status	74.6 (78,384)
No or Ex-smoker		81.6 (63,943)
Current smoker		18.4 (14,441)

NOTE: ^† Included were four major diabetes complications: angina pectoris, myocardial infarction (MI), stroke, transient ischemic attack (TIA).

ISSN: 1471-2288